Literature DB >> 25575733

Artemisinin inhibits the proliferation, migration, and inflammatory reaction induced by tumor necrosis factor-α in vascular smooth muscle cells through nuclear factor kappa B pathway.

Qian Cao1, Yan Jiang2, Jin Shi3, Changlu Xu3, Xiaoxia Liu3, Tiangui Yang3, Peng Fu3, Tiesheng Niu3.   

Abstract

BACKGROUND: Atherosclerosis is an inflammatory disease with the most common pathologic process leading to cardiovascular diseases. The aim of this study was to evaluate the effect of artemisinin (ART) on the proliferation, migration, and inflammation induced by tumor necrosis factor-α (TNF-α) of rat vascular smooth muscle cells (VSMCs).
MATERIALS AND METHODS: Primary rat VSMCs were pretreated with ART and then co-incubated with TNF-α. Cell proliferation was evaluated by MTT assay. Cell migration was assessed by transwell assay. Reactive oxygen species (ROS) production was measured by flow cytometry after staining with dichloro-dihydro-fluorescein diacetate. Inflammation factors of nitric oxide and prostaglandin E2 (PGE2) were measured by responding assay kits. Expression levels of nuclear factor kappa B (NF-κB) subunit NF-κB p65 and the regulator inhibitor of nuclear factor kappa-B kinase-alpha (IκBα) were tested by Western blot, meanwhile, the activation of NF-κB was observed by immunofluorescence assay.
RESULTS: The proliferation, migration, and inflammation of VSMCs induced by TNF-α were significantly inhibited by ART treatment in a dose-dependent manner. Treatment with 100 μM ART for 2 h significantly reduced the expression of proliferating cell nuclear antigen and migration-related proteins matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). On the other hand, the same treatment decreased the inflammation factors production of nitric oxide and PGE2. Fluorescence-activated cell sorting analysis revealed that ART suppressed the ROS production induced by TNF-α. Western blot analysis showed that both inflammation mediators inducible nitric oxide synthase and cyclooxygenase and the NF-κB pathway subunit NF-κB p65 were downregulated by ART.
CONCLUSIONS: The results suggest that ART can effectively inhibit the proliferation, migration, and inflammation of VSMCs induced by TNF-α through ROS-mediated NF-κB signal pathway.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artemisinin; Cell proliferation; Migration and inflammation; TNF-α; Vascular smooth muscle cells (VSMCs)

Mesh:

Substances:

Year:  2014        PMID: 25575733     DOI: 10.1016/j.jss.2014.12.013

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  17 in total

1.  Role of dihydroartemisinin in regulating prostaglandin E2 synthesis cascade and inflammation in endothelial cells.

Authors:  Jie Yin; Weiwei Xia; Yue Zhang; Guixia Ding; Lihong Chen; Guangrui Yang; Songming Huang; Zhanjun Jia; Aihua Zhang
Journal:  Heart Vessels       Date:  2018-05-23       Impact factor: 2.037

2.  Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model.

Authors:  Mao-Song Xie; Yong-Zheng Zheng; Li-Bin Huang; Guo-Xing Xu
Journal:  Int J Ophthalmol       Date:  2017-12-18       Impact factor: 1.779

3.  Ox-LDL Upregulates IL-6 Expression by Enhancing NF-κB in an IGF2-Dependent Manner in THP-1 Macrophages.

Authors:  Yan-Chao Wang; Yan-Wei Hu; Yan-Hua Sha; Ji-Juan Gao; Xin Ma; Shu-Fen Li; Jia-Yi Zhao; Yu-Rong Qiu; Jing-Bo Lu; Chuan Huang; Jing-Jing Zhao; Lei Zheng; Qian Wang
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

4.  Role of parnaparin in atherosclerosis.

Authors:  Francesca Bonomini; Samanta Taurone; Pierpaolo Parnigotto; Loris Zamai; Luigi F Rodella; Marco Artico; Rita Rezzani
Journal:  Int J Exp Pathol       Date:  2017-02-16       Impact factor: 1.925

5.  Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.

Authors:  Changlei Bao; Qian He; Hui Wang; Yanan Sun; Yahang Xu; Yan Pan; Yadan Hu; Shichuang Zheng; Shuxin Liang; Ang Luo; Tanzilan Nahar; Jiwang Chen; Haiyang Tang; Ying Han
Journal:  Oxid Med Cell Longev       Date:  2022-06-17       Impact factor: 7.310

Review 6.  Artemisinin and its derivatives: a potential therapeutic approach for oral lichen planus.

Authors:  Rui-Jie Ma; Ming-Jing He; Ya-Qin Tan; Gang Zhou
Journal:  Inflamm Res       Date:  2019-02-01       Impact factor: 4.575

7.  Development of a Specific Monoclonal Antibody for the Quantification of Artemisinin in Artemisia annua and Rat Serum.

Authors:  Suqin Guo; Yongliang Cui; Kunbi Wang; Wei Zhang; Guiyu Tan; Baomin Wang; Liwang Cui
Journal:  Anal Chem       Date:  2016-02-15       Impact factor: 6.986

8.  Anti-Inflammatory Effect of Gallic Acid-Eluting Stent in a Porcine Coronary Restenosis Model.

Authors:  Kyung Seob Lim; Jun-Kyu Park; Myung Ho Jeong; In Ho Bae; Dae Sung Park; Jae Won Shim; Jung Ha Kim; Hyun Kuk Kim; Sung Soo Kim; Doo Sun Sim; Young Joon Hong; Ju Han Kim; Youngkeun Ahn
Journal:  Acta Cardiol Sin       Date:  2018-05       Impact factor: 2.672

9.  MicroRNA-1246 regulates proliferation, invasion, and differentiation in human vascular smooth muscle cells by targeting cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Diguang Pan; Guiyong Liu; Bin Li; Jingbo Jiang; Wei Chen; Wei Li; Lin Zhang; Yubao Hu; Shuyun Xie; Huayun Yang
Journal:  Pflugers Arch       Date:  2021-01-08       Impact factor: 3.657

10.  Artemisinin Protects Porcine Mammary Epithelial Cells against Lipopolysaccharide-Induced Inflammatory Injury by Regulating the NF-κB and MAPK Signaling Pathways.

Authors:  Wenfei Zhang; Liang Xiong; Jiaming Chen; Zhezhe Tian; Jiaxin Liu; Fang Chen; Man Ren; Wutai Guan; Shihai Zhang
Journal:  Animals (Basel)       Date:  2021-05-24       Impact factor: 2.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.